CARDIFF-BY-THE-SEA, Calif., Mar. 16, 2026 — Field Medical, Inc., a clinical-stage medical technology company advancing second-generation pulsed field ablation (PFA) solutions for complex ventricular and atrial arrhythmias, today announced the appointment of Mark A. Turco, MD, as chief executive officer, effective immediately.
Read the full press release here.
CARDIFF-BY-THE-SEA, Calif., Feb. 5, 2026 /PRNewswire/ -- Field Medical, Inc., a clinical-stage medical technology company advancing pulsed field ablation (PFA) solutions for complex cardiac arrhythmias, today announced the presentation of late breaking clinical trial data from the first-in-human Field PULSE study at the 31st Annual International AF Symposium 2026, held February 5–7 in Boston.
Read the full press release here.
Field Medical announced that its founder, Steven Mickelsen, MD, will present at the 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026, in San Francisco. The presentation will provide a company overview and highlight progress across the FieldForce™ PFA platform, including ventricular tachycardia and atrial fibrillation programs.
Read the full press release here.